ColgatePalmolive (CL)
(Delayed Data from NYSE)
$92.57 USD
+1.80 (1.98%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $92.61 +0.04 (0.04%) 5:10 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$92.57 USD
+1.80 (1.98%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $92.61 +0.04 (0.04%) 5:10 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Zacks News
Will Clorox (CLX) Retain Positive Earnings Trend in Q3?
by Zacks Equity Research
Clorox's (CLX) weak margin in the last reported quarter is expected to continue in the fiscal third quarter. However, the company's approach toward brand management and Go Lean strategy are impressive.
What's in the Offing for Archer Daniels' (ADM) Q1 Earnings?
by Zacks Equity Research
Archer Daniels (ADM) remains optimistic about delivering growth via cost-savings efforts, innovations and global strength. However, the company has a dismal sales history for more than three years.
Why Colgate-Palmolive (CL) Might Surprise This Earnings Season
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Why Is Colgate-Palmolive (CL) Down 9.1% Since its Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson
Will New Products Lift Procter & Gamble's (PG) Q2 Sales?
by Zacks Equity Research
Soft consumer-spending environment and higher competition in developed markets might hurt Procter & Gamble's (PG) Q2 sales. However, new product launches are likely to offset the negatives.
5 Reasons Why Clorox (CLX) is a Must Add Stock Right Now
by Zacks Equity Research
The Clorox Inc. (CLX) stock has been moving up the charts, thanks to the smooth execution of its 2020 strategy. By its actions, the company is poised to boost growth for its categories as well as overall market share.
Colgate (CL) Q3 Earnings in Line, Sales Beat, Stock Down
by Zacks Equity Research
Colgate (CL) came out with third-quarter 2017 adjusted earnings of 73 cents per share, which came in line with Zacks Consensus Estimate.
Will V.F. Corp (VFC) Strategies Facilitate Q3 Earnings Beat?
by Zacks Equity Research
We expect the designer, manufacturer and marketer of branded apparel and related products, V. F. Corporation (VFC) to beat expectations when it reports third-quarter 2017 results on Oct 23.
Will Colgate's Strategic Initiatives Help Counter Sales Woes?
by Zacks Equity Research
Colgate-Palmolive (CL) remains committed to its savings programs with a disciplined capital strategy. However, the company has a dismal sales trend.
Clorox's (CLX) Long-Term Strategy Bode Well: Here's Why
by Zacks Equity Research
The Clorox Company (CLX) remains keen on the smooth execution of its 2020 Strategy, which is aimed at boosting growth for the improvement of categories and overall market share.
Colgate (CL) Dips Despite In-Line Q2 Earnings, Sales Lag
by Zacks Equity Research
Despite in-line earnings, Colgate-Palmolive Co. (CL) shares dipped 2.3% in pre-market trading hours, due to skepticism on its top-line performance and soft organic sales view.
Colgate (CL) Q2 Earnings in Line, Stock Down on Sales Miss
by Zacks Equity Research
Colgate-Palmolive (CL) came out with second-quarter 2017 results, wherein sales continued to lag estimates, leading to a revised outlook.
Church & Dwight (CHD) Shares Up on Water Pik Buyout Talks
by Zacks Equity Research
The acquisition of Water Pik will complement and expand Church & Dwight's (CHD) oral care portfolio.
3 Consumer Staples Stocks With Strong Growth Prospects
by Zacks Equity Research
Our research shows that stocks with Growth Style Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer the best investment opportunities in the growth investing space and certainly have bright prospects to ride out the impending volatility.
What Makes Colgate-Palmolive (CL) a Treasured Holding?
by Zacks Equity Research
Investors of the leading consumer products company, Colgate-Palmolive Company (CL) will agree to the fact that this stock has never let them down.
Colgate-Palmolive (CL) Up 2.9% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colgate-Palmolive (CL) In Focus: Stock Adds 5.7% in Session
by Zacks Equity Research
Colgate-Palmolive Company (CL) moved big last session, as its shares jumped almost 6% on the day.
Top Research Reports for Today: MA, CVS, CL & More
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including MasterCard (MA), CVS Health (CVS) and Colgate-Palmolive (CL).
What's in Store for Reynolds American (RAI) in Q1 Earnings?
by Zacks Equity Research
Reynolds American, Inc. (RAI) is set to report first-quarter 2017 results before the opening bell on May 3.
Colgate (CL) Beats on Q1 Earnings, Stock Down on Sales Miss
by Zacks Equity Research
Colgate-Palmolive Co. (CL), a global dealer in consumer goods, came out with first-quarter 2017 adjusted earnings of 67 cents per share surpassed the Zacks Consensus Estimate by a penny.
Procter & Gamble (PG) Tops Q3 Earnings Estimates, Sales Dip
by Zacks Equity Research
The Procter & Gamble Company (PG), popularly known as P&G, reported third-quarter fiscal 2017 financial results, wherein earnings exceeded expectations, while revenues missed the same.
Top Research Reports for Today: JNJ, VZ, V
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Verizon (VZ), and Visa (V).
The Zacks Analyst Blog Highlights: ExxonMobil, Colgate-Palmolive, Honeywell, Verizon and United Technologies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Colgate-Palmolive, Honeywell, Verizon and United Technologies
The Zacks Analyst Blog Highlights: ConocoPhillips, Colgate-Palmolive, Vale, State Street and Bayer
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ConocoPhillips, Colgate-Palmolive, Vale, State Street and Bayer